NCT01704508View on ClinicalTrials.gov

Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A

PHASE4CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

October 31, 2015

Study Completion Date

July 31, 2016

Conditions
Malaria
Interventions
DRUG

Artemether-lumefantrine

DRUG

Dihydroartemisinin-piperaquine

Trial Locations (1)

Unknown

Bandim Health Project, Bissau

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Bandim Health Project

OTHER

NCT01704508 - Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A | Biotech Hunter | Biotech Hunter